No data available.
Hydroxyamphetamine is a derivative of amphetamines. Hydroxyamphetamine is intended mainly as local eye drops for diagnostic purposes. It is indirect sympathomimetic agent which cause dilation of the eye pupil before diagnostic test. Among the minor side effects from its use are: change in color vision, difficulty seeing at night, dry mouth, headache, increased sensitivity of eyes to sunlight, muscle stiffness or tightness and temporary stinging in the eyes.
The main use of hydroxyamphetamines as eye drops is the diagnosis of Horner's syndrome which is characterized by nerve lesions.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Caffeine | The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with Caffeine. |
| Theophylline | The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with Theophylline. |
| Dyphylline | The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with Dyphylline. |
| Pentoxifylline | The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with Pentoxifylline. |
| Mercaptopurine | The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with Mercaptopurine. |
| Aminophylline | The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with Aminophylline. |
| Oxtriphylline | The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with Oxtriphylline. |
| Theobromine | The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with Theobromine. |
| Fenethylline | The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with Fenethylline. |
| 8-azaguanine | The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with 8-azaguanine. |
| 7,9-Dimethylguanine | The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with 7,9-Dimethylguanine. |
| Xanthine | The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with Xanthine. |
| 7-Deazaguanine | The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with 7-Deazaguanine. |
| Guanine | The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with Guanine. |
| 9-Methylguanine | The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with 9-Methylguanine. |
| Peldesine | The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with Peldesine. |
| Hypoxanthine | The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with Hypoxanthine. |
| 9-Deazaguanine | The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with 9-Deazaguanine. |
| Propentofylline | The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with Propentofylline. |
| Valomaciclovir | The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with Valomaciclovir. |
| 3-isobutyl-1-methyl-7H-xanthine | The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with 3-isobutyl-1-methyl-7H-xanthine. |
| Uric acid | The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with Uric acid. |
| Doxofylline | The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with Doxofylline. |
| 6-O-benzylguanine | The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with 6-O-benzylguanine. |
| Lisofylline | The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with Lisofylline. |
| Lobucavir | The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with Lobucavir. |
| Cafedrine | The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with Cafedrine. |
| Theodrenaline | The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with Theodrenaline. |
| Bamifylline | The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with Bamifylline. |
| Proxyphylline | The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with Proxyphylline. |
| Acefylline | The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with Acefylline. |
| Etamiphylline | The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with Etamiphylline. |
| Pentifylline | The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with Pentifylline. |
| Bufylline | The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with Bufylline. |
| Bromotheophylline | The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with Bromotheophylline. |
| Furafylline | The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with Furafylline. |
| 8-chlorotheophylline | The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with 8-chlorotheophylline. |
| PCS-499 | The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with PCS-499. |
| Trazodone | The risk or severity of serotonin syndrome can be increased when Trazodone is combined with Hydroxyamphetamine. |
| Glyburide | The therapeutic efficacy of Glyburide can be decreased when used in combination with Hydroxyamphetamine. |
| Escitalopram | The risk or severity of serotonin syndrome can be increased when Hydroxyamphetamine is combined with Escitalopram. |
| Lasmiditan | The risk or severity of serotonin syndrome can be increased when Lasmiditan is combined with Hydroxyamphetamine. |
| Formoterol | Hydroxyamphetamine may increase the sympathomimetic activities of Formoterol. |
| Tramadol | The risk or severity of serotonin syndrome can be increased when Hydroxyamphetamine is combined with Tramadol. |
| Fluoxetine | The risk or severity of serotonin syndrome can be increased when Hydroxyamphetamine is combined with Fluoxetine. |
| Fenfluramine | The risk or severity of serotonin syndrome can be increased when Hydroxyamphetamine is combined with Fenfluramine. |
| Acetazolamide | Acetazolamide may decrease the excretion rate of Hydroxyamphetamine which could result in a higher serum level. |
| Oliceridine | The risk or severity of serotonin syndrome can be increased when Hydroxyamphetamine is combined with Oliceridine. |
| Lamotrigine | The therapeutic efficacy of Lamotrigine can be decreased when used in combination with Hydroxyamphetamine. |
| Venlafaxine | The risk or severity of serotonin syndrome can be increased when Hydroxyamphetamine is combined with Venlafaxine. |
| Tapentadol | The risk or severity of serotonin syndrome can be increased when Hydroxyamphetamine is combined with Tapentadol. |
| Levomilnacipran | The risk or severity of serotonin syndrome can be increased when Hydroxyamphetamine is combined with Levomilnacipran. |
| Desvenlafaxine | The risk or severity of serotonin syndrome can be increased when Desvenlafaxine is combined with Hydroxyamphetamine. |
| Lisdexamfetamine | The risk or severity of serotonin syndrome can be increased when Hydroxyamphetamine is combined with Lisdexamfetamine. |
| Gepirone | The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Hydroxyamphetamine. |
| Lomifylline | The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with Lomifylline. |